2016

Infliximab vs cyclosporine in ASUC

Adalimumab +/- azathioprine in CD

Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study

Treatment of CD with an IgG4-Guided Exclusion Diet

Ustekinumab in CD safety

Methotrexate in UC

Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: theMOMENTUM Trial

Infliximab in postoperative recurrence CD

Ozanimod in UC

Mercaptopurine in postoperative recurrence CD